US Distribution Update

RNS Number : 1068Q
Zoetic International PLC
24 February 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

24 February 2021

 

Zoetic International plc

('Zoetic' or the 'Group')

 

Update on the rollout of the original US Distribution Agreement

 

Zoetic (LSE: ZOE), the international CBD group, is pleased to provide the following update on its operations.


Further to the rollout of the new distribution agreement (the 'Agreement'), announced on
19 November 2020 , Zoetic's Chill brand of tobacco alternative CBD products is now set to be stocked by one of the largest tobacco-focused retail chains in the US (the 'Retail Chain'), which previously oversaw the growth of one of America's highest-selling tobacco-free nicotine pouch brands. The Group expects to grow market share due to the Retail Chain's significant number of high footfall stores that will sell Chill products from high-visibility point of sale display stands.

 

The Group will provide further updates in due course as the rollout continues.

 

Antonio Russo, Co-CEO of Zoetic, commented: "This Agreement marks a pivotal moment in the progress of our US rollout and demonstrates the high calibre of retail placements that our distribution partners continue to make. Our Chill products will now benefit from the established reputation of one of the largest tobacco-focused retail chains in the US. This chain was instrumental in the success of other tobacco alternative products in stores and we are hopeful that we will receive similarly positive results, establishing Chill as one of America's favourite CBD brands."

 

- Ends -

 

Media enquiries:

Zoetic International plc  

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

 

 

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

 

Nick Naylor (Corporate Finance)

 

Guy McDougall (Equity Sales)

 

 

 

Buchanan

 

Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

Tel: +44 (0) 20 7466 5000

zoetic@buchanan.uk.com

www.buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSEAFUDEFSESE
UK 100

Latest directors dealings